Learn More
Bio X Cell InVivoSIM anti-human VEGFR-2, Ramucirumab Biosimilar, 50 MG
Supplier: Bio X Cell SIM0012R050MG
This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Ramucirumab. It interacts with human VEGFR-2, also known as CD309, KDR, and Flk-1, which is crucial for vascular development and permeability. Ramucirumab binds to the extracellular domain of VEGFR-2, inhibiting VEGF-mediated tumor angiogenesis.
- Clone: Ramucirumab
- Reactivities: Human
- Isotype: Human IgG1
- Conjugation: Unconjugated
- Immunogen: Human VEGFR2
- Reported applications: Functional assays, immunohistochemistry, flow cytometry
- Formulation: PBS, pH 7.0 (contains no stabilizers or preservatives)
- Endotoxin: ≤0.5EU/mg
- Purity: ≥95%
- Sterility: 0.2 μm filtration
- Molecular weight: 150 kDa
- Storage: Store at 4°C, do not freeze
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.